Benign prostatic hyperplasia (BPH) is a urological disorder characterized by non-cancerous proliferation of prostate gland cells. This condition causes the gland to enlarge and, as a result, press against the urethra, constricting urine flow. This disorder is associated with aging, hormone imbalances, and abnormal cell growth.
The global benign prostatic hyperplasia market is expected to show considerable growth during the forecast period. This is attributed to rising geriatric population, increased awareness for prostate cancer and other urological disorders. However, the factors such as a dearth of the urologist in developing economies and lack of awareness regarding various urological diseases can hinder the growth of the market in the coming years. North America is account for the largest share of the benign prostatic hyperplasia market due to a high prevalence rate of benign prostatic hyperplasia. However, Asia is the fastest growing market due to the rise in various urological disorders and complications
Global Benign Prostatic Hyperplasia Devices Market Professional Survey Report 2019 is a professional and in-depth study and available exclusively through Trusted Business Insights. Annual estimates and forecasts are provided for the period 2019 through 2025. Also, a five-year historic analysis is provided for these markets in this 120 pages report.
This market report provides in-depth analytics of the Benign Prostatic Hyperplasia Devices industry including definition, classification, application and industry chain structure. The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share, and contact information.
Benign Prostatic Hyperplasia Devices market report includes an in-depth analysis of the competitive landscape of this business vertical, constituting companies like:
Boston Scientific corporation
ProArc Medical LTD
Products Segmentation, this report displays the production, revenue, price, market share, and growth rate of each type as below:
Transurethral Resection of the Prostate (TURP)
Transurethral Microwave Therapy (TUMT)
Transurethral Needle Ablation of the Prostate (TUNA)
By Industrial Application, the market can be split into:
Hospitals and Clinics
Ambulatory Surgical Centers(ASC)
Market Segment by Regions includes:
- North America (the USA, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, and Italy)
- Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
- South America
- Middle East and Africa.
Trusted Business Insights
Joseph Anthony Jones
Senior Media & Marketing Executive
US: +1 646 568 9797
UK: +44 330 808 0580